Related Experiment Videos

Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor

Cancer Research
|May 1, 1986
PubMed

Insights

Pancreatic cancer cells (HPAF) possess oncogene activity, identified by transforming NIH 3T3 cells. This activity involves unique proteins, not known oncogenes, found in other pancreatic tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic adenocarcinoma is a significant cause of cancer mortality.
  • Identifying oncogenes in cancer cells is crucial for understanding tumor development and for targeted therapies.

Purpose of the Study:

  • To investigate the presence of oncogene activity in the HPAF pancreatic adenocarcinoma cell line.
  • To characterize the molecular basis of this oncogenic activity.

Main Methods:

  • DNA transfection of NIH 3T3 cells with HPAF DNA.
  • Analysis of oncogene homology using Southern blotting (implied).
  • Two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (2D SDS-PAGE) to detect protein expression.
  • Monoclonal antibody production and characterization.

Main Results:

  • HPAF DNA induced transformation of NIH 3T3 cells, indicating oncogene activity.
  • No known oncogenes (ras, myc, src, etc.) were detected in transfectants, other than endogenous mouse genes.
  • Transfected cells expressed unique proteins not present in NIH 3T3 cells.
  • These unique proteins were antigenically identical to proteins in HPAF cells and present in other pancreatic cancer cell lines, but not in other cancer types or normal fibroblasts.

Conclusions:

  • The HPAF cell line harbors oncogene activity distinct from known oncogenes.
  • This activity is associated with the expression of specific proteins that are characteristic of pancreatic adenocarcinoma.
  • These findings suggest potential biomarkers for pancreatic cancer detection or therapeutic targets.

Related Concept Videos